$13.95
▲ +3.7% Today
as of Sep 4, 16:53 ET
Last 30 days
Recent Press Releases & News
Paysign Targets $117M Revenue as Patient-Affordability Business Surges
Paysign (PAYS) is an Incredible Growth Stock: 3 Reasons Why
Paysign (PAYS) Upgraded to Buy: What Does It Mean for the Stock?
Overview
52-week range
$3.08
$14
96% of range
Avg surprise (last 1)
-43.8%
Avg reaction (last 2)
+7.8%
50% positive
Latest IV / EM
61%
EM ±9.5% · $13 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $0.11 | — | — | — | — | financials |
| Tue May 12, 2026 | Mar/2026 | $0.09 | $0.16 | -43.8% | +80.0% | -0.7% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $0.04 | — | — | — | — | financials |
| Tue Aug 5, 2025 | Jun/2025 | $0.02 | — | — | — | — | earnings |
| Thu May 8, 2025 | Mar/2025 | $0.05 | — | — | — | +16.3% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $0.03 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $0.01 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $0.01 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $0.02 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | — | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | — | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $28M | $28M | — | $22M | $19M | $19M | — | $15M |
| Cost of revenue | $10M | $10M | — | $9M | $7M | $7M | — | $7M |
| Gross profit | $18M | $18M | — | $12M | $12M | $12M | — | $8M |
| Operating income | $7M | $7M | — | $2M | $1M | $2M | — | $689,849 |
| Net income | $7M | $5M | — | $2M | $1M | $3M | — | $1M |
| EPS (diluted) | $0.11 | $0.09 | — | $0.04 | $0.02 | $0.05 | — | $0.03 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $27M | $21M | $21M | $8M | $12M | $7M | — | $10M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $283M | $277M | $240M | $171M | $159M | $167M | $159M | $147M |
| Total assets | $317M | $313M | $276M | $210M | $194M | $205M | $179M | $167M |
| Long-term debt | $4M | $5M | $6M | $6M | $6M | $8M | $0 | — |
| Total liabilities | $257M | $258M | $228M | $164M | $152M | $166M | $149M | $138M |
| Total equity | $60M | $55M | $48M | $46M | $42M | $39M | $30M | $29M |